Edward T Mathers Monte Rosa Therapeutics, Inc. (GLUE) insider trading activity

GLUE Quotes by TradingView

Edward T Mathers Transaction History

Date Transaction Value Shares Traded Form
Jun 28 2021
BUY
Open market or private purchase
$19,950,000 $19.0 p/Share
1,050,000
Jun 28 2021
BUY
Conversion of derivative security
-
6,642,298

Also insider at

RPHM
Reneo Pharmaceuticals, Inc. Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
Director
RYTM
RHYTHM PHARMACEUTICALS, INC. Healthcare
SYBX
SYNLOGIC, INC. Healthcare
Director
TRVI
Trevi Therapeutics, Inc. Healthcare
INZY
Inozyme Pharma, Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
Director
SNTI
Senti Biosciences, Inc. Healthcare
BHG
Bright Health Group Inc. Healthcare
SVRA
Savara Inc Healthcare
> 10% Shareholder
FREQ
Frequency Therapeutics, Inc. Healthcare
MBX
MBX Biosciences, Inc.
ETM

Edward T Mathers

> 10% Shareholder
Timonium, MD

Track Institutional and Insider Activities on GLUE

Follow Monte Rosa Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLUE shares.

Notify only if

Insider Trading

Get notified when an Monte Rosa Therapeutics, Inc. insider buys or sells GLUE shares.

Notify only if

News

Receive news related to Monte Rosa Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GLUE